Skip to main content
MPX International Corporation logo

MPX International Corporation — Investor Relations & Filings

Ticker · MPXOF ISIN · US55344L1364 LEI · 549300ZZO3GIWTIBYY96 CSE Manufacturing
Open in API
Filings indexed 154 across all filing types
Latest filing 2022-08-04 Regulatory Filings
Country CA Canada
Listing CSE MPXOF

About MPX International Corporation

https://mpxinternationalcorp.com

MPX International Corporation is a multinational diversified biopharma and cannabis company focused on developing and operating assets across the international cannabis sector. The company manages fully integrated operations spanning cultivation, extraction, formulation, and retail. Cultivation utilizes both highly-automated indoor grows and certified organic sun-grown methods, serving regulated medical and consumer markets. MPX specializes in best-in-class concentrates and extracts, implementing proprietary SOPs developed to sophisticated US standards within GMP medical production facilities. The product portfolio includes over 150 SKUs (medical and consumer/wellness), formulated using up to nine different cannabinoids, ensuring consistent quality across all markets. Retail operations, including Beleaf and HolyWeed stores, focus on education and pioneering consumer experiences.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing the commencement of a court-approved sale and investment solicitation process for MPX International Corporation. It references court orders under the Companies’ Creditors Arrangement Act (CCAA) and details the sale process timeline and contact information for the monitor. There are no financial statements, earnings data, or detailed management discussion. The document is an announcement related to restructuring and sale process initiation, not a financial report or regulatory filing of financial results. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or M&A filings. It is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about the company's restructuring and sale process, which does not fit other specific categories.
2022-08-04 English
News release - English.pdf
Legal Proceedings Report Classification · 95% confidence The document is a press release announcing that MPX International Corporation and its subsidiaries have obtained creditor protection under the Companies’ Creditors Arrangement Act (CCAA) to pursue restructuring and a sales process. It details the court order, debtor-in-possession financing, appointment of a monitor, and plans for a sale and investment solicitation process. It also announces the cancellation of the annual meeting of shareholders due to the court order. The document does not contain financial statements or detailed financial analysis but is an update on the company's restructuring and legal proceedings. This fits the category of a Legal Proceedings Report (LTR) as it provides updates on significant legal and restructuring actions involving the company.
2022-07-26 English
Notice of the meeting and record date (amended) - English.pdf
AGM Information Classification · 95% confidence The document is a communication to securities commissions regarding details about an upcoming Annual Meeting of Shareholders for MPX International Corporation. It includes dates related to the meeting, record dates for notice and voting, securities entitled to vote, and information about mailing and notice-and-access procedures. The document is short (1325 characters) and does not contain financial statements or detailed financial data. It is clearly an announcement related to the Annual General Meeting (AGM) logistics and shareholder meeting details, not the AGM materials themselves or the voting results. Therefore, it fits the category of AGM Information (AGM-R).
2022-07-13 English
News release - English.pdf
AGM Information Classification · 95% confidence The document is a press release announcing the postponement of the company's Annual General Meeting (AGM) of shareholders. It does not contain any financial statements, detailed financial performance data, or substantive financial analysis. It also does not include voting results or proxy materials. The document is primarily an announcement about the scheduling of the AGM, which fits the category of AGM Information (AGM-R). The document length is under 5,000 characters and it is not a report publication announcement or regulatory filing. Therefore, the most appropriate classification is AGM Information (AGM-R).
2022-07-13 English
Notice of meeting - English.pdf
Regulatory Filings
2022-06-30 English
Notice of the meeting and record date (amended) - English.pdf
Regulatory Filings
2022-05-31 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.